<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="15/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10092783" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>10092783</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T2" lex="IL-2">IL-2</term>-mediated <term sem="Other" id="T46"><term sem="Other" id="A1">cell cycle</term> progression</term> and inhibition of <term sem="Other" id="T3" lex="apoptosis">apoptosis</term> does not require <term sem="Protein_complex" id="T4" lex="NF-kappa_B">NF-kappa B</term> or <term sem="Protein_complex" id="A2">activating protein-1</term> activation in <term sem="Cell_natural" id="A3">primary human T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="A1" />
<clue>IL-2-mediated cell cycle <clueType>progression</clueType> and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="T3" />
<clue>IL-2-mediated cell cycle progression and <clueType>inhibition</clueType> <linkTheme>of</linkTheme> apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="T2" />
<clue>IL-2-<clueType>mediated</clueType> cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="E2" />
<cause idref="T2" />
<clue>IL-2-<clueType>mediated</clueType> cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T4" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 <clueType>activation</clueType> in primary human T cells.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="A2" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 <clueType>activation</clueType> in primary human T cells.</clue>
</event>
<event assertion="non-exist" id="E7">
<type class="Correlation" />
<theme idref="E3" />
<theme idref="E5" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E8">
<type class="Correlation" />
<theme idref="E3" />
<theme idref="E6" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E9">
<type class="Correlation" />
<theme idref="E4" />
<theme idref="E5" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E10">
<type class="Correlation" />
<theme idref="E4" />
<theme idref="E6" />
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term sem="Protein_molecule" id="T5" lex="IL-2">IL-2</term> growth hormone is the major growth factor of activated <term sem="Cell_natural" id="T6" lex="T_lymphocyte">T lymphocytes</term> during a developing <term sem="Other" id="T1">immune response</term>.</sentence>
<sentence id="S3"><term sem="Protein_molecule" id="T8" lex="IL-2">IL-2</term> is required not only for <term sem="Other" id="A4">cell cycle</term> progression but also to protect <term sem="Cell_natural" id="T9" lex="Ag-activated_T_cell">Ag-activated T cells</term> from <term sem="Other" id="T10" lex="programmed_cell_death">programmed cell death</term>.</sentence>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="A4" />
<clue>IL-2 is required not only for cell cycle <clueType>progression</clueType> but also to protect Ag-activated T cells from programmed cell death.</clue>
</event>
<event id="E12">
<type class="Negative_regulation" />
<theme idref="T10" />
<clue>IL-2 is required not only for cell cycle progression but also to <clueType>protect</clueType> <clueLoc>Ag-activated T cells</clueLoc> <linkTheme>from</linkTheme> programmed cell death.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E11" />
<cause idref="T8" />
<clue>IL-2 is <clueType>required</clueType> not only <linkTheme>for</linkTheme> cell cycle progression but also to protect Ag-activated T cells from programmed cell death.</clue>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T8" />
<clue>IL-2 is <clueType>required</clueType> not only for cell cycle progression but also <linkTheme>to</linkTheme> protect Ag-activated T cells from programmed cell death.</clue>
</event>
<sentence id="S4">In several cell types, activation of <term sem="Protein_complex" id="T11" lex="NF-kappa_B">NF-kappa B</term> and/or <term sem="Protein_complex" id="T12" lex="activating_protein-1">activating protein-1</term> (<term sem="Protein_complex" id="T13" lex="AP-1">AP-1</term>) has been demonstrated to be extremely important in blocking <term sem="Other" id="T14" lex="apoptosis">apoptosis</term>.</sentence>
<event id="E15">
<type class="Negative_regulation" />
<theme idref="T14" />
<clue>In several cell types, activation of NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in <clueType>blocking</clueType> apoptosis.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T11" />
<clue>In several cell types, <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in blocking apoptosis.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T13" />
<clue>In several cell types, <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in blocking apoptosis.</clue>
<comment>NER T12,T13 mod</comment>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="E16" />
<clue><clueLoc>In several cell types</clueLoc>, activation of NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to <clueType>be</clueType> extremely <clueType>important</clueType> <linkTheme>in</linkTheme> blocking apoptosis.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="E17" />
<clue><clueLoc>In several cell types</clueLoc>, activation of NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to <clueType>be</clueType> extremely <clueType>important</clueType> <linkTheme>in</linkTheme> blocking apoptosis.</clue>
</event>
<sentence id="S5">To determine whether either or both of these <term sem="Protein_family_or_group" id="T15" lex="transcription_factor">transcription factors</term> are involved in <term sem="Other" id="T16" lex="cell_survival"><term sem="Cell_natural" id="A6">cell</term> survival</term> or <term sem="Other" id="T17" lex="cell_cycle_progression"><term sem="Other" id="A5">cell cycle</term> progression</term> in response to <term sem="Protein_molecule" id="T18" lex="IL-2">IL-2</term>, <term sem="Cell_natural" id="T19" lex="primary_human_T_cell">primary human T cells</term> responsive to the growth factor were analyzed for <cons sem="(AND Other Other)" id="T20" lex="(AND NF-kappa_B_activation AP-1_activation)"><frag id="F1">NF-kappa B</frag> and <frag id="F2">AP-1</frag> <frag id="F3">activation</frag></cons>.</sentence>
<event id="E20">
<type class="Cellular_physiological_process" />
<theme idref="A6" />
<clue>To determine whether either or both of these transcription factors are involved in cell <clueType>survival</clueType> or cell cycle progression <linkCause>in response to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E50">
<type class="Regulation" />
<theme idref="E20" />
<cause idref="T18" />
<clue>To determine whether either or both of these transcription factors are involved in cell survival or cell cycle progression in <clueType>response</clueType> <linkCause>to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="A5" />
<cause idref="T18" />
<clue>To determine whether either or both of these transcription factors are involved in cell survival or cell cycle <clueType>progression</clueType> <linkCause>in response to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event uncertainty="doubtful" id="E22">
<type class="Correlation" />
<theme idref="E50" />
<theme idref="T11" />
<clue>To determine whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event uncertainty="doubtful" id="E51">
<type class="Correlation" />
<theme idref="E50" />
<theme idref="T13" />
<clue>To determine whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event uncertainty="doubtful" id="E23">
<type class="Correlation" />
<theme idref="E21" />
<theme idref="T11" />
<clue>To determine whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event uncertainty="doubtful" id="E52">
<type class="Correlation" />
<theme idref="E21" />
<theme idref="T13" />
<clue>To determine whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<sentence id="S6">The current study clearly demonstrates that <term sem="Protein_molecule" id="T21" lex="IL-2">IL-2</term> does not induce <term sem="Other" id="T22" lex="I_kappa_B_alpha_degradation"><term sem="Protein_molecule" id="T23" lex="I_kappa_B">I kappa B alpha</term> degradation</term> or <term sem="Protein_complex" id="T24" lex="NF-kappa_B">NF-kappa B</term> activation in <term sem="Cell_natural" id="T25" lex="primary_human_T_cell">primary human T cells</term> that respond to <term sem="Protein_molecule" id="T26" lex="IL-2">IL-2</term> by entering the <term sem="Other" id="A7">cell cycle</term> and avoiding <term sem="Other" id="T27" lex="apoptosis">apoptosis</term>.</sentence>
<event id="E24">
<type class="Protein_catabolism" />
<theme idref="T23" />
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha <clueType>degradation</clueType> or NF-kappa B activation in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
<comment>NER T23 mod</comment>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="T24" />
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B <clueType>activation</clueType> in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event assertion="non-exist" id="E26">
<type class="Positive_regulation" />
<theme idref="E24" />
<cause idref="T21" />
<clue>The current study clearly demonstrates that IL-2 does not <clueType>induce</clueType> I kappa B alpha degradation or NF-kappa B activation <clueLoc>in primary human T cells</clueLoc> that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event assertion="non-exist" id="E27">
<type class="Positive_regulation" />
<theme idref="E25" />
<cause idref="T21" />
<clue>The current study clearly demonstrates that IL-2 does not <clueType>induce</clueType> I kappa B alpha degradation or NF-kappa B activation <clueLoc>in primary human T cells</clueLoc> that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event id="E28">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="T26" />
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B activation in <clueLoc>primary human T cells</clueLoc> that <linkCause>respond to</linkCause> IL-2 by <clueType>entering</clueType> the cell cycle and avoiding apoptosis.</clue>
</event>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="T27" />
<cause idref="T26" />
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B activation in <clueLoc>primary human T cells</clueLoc> that <linkCause>respond to</linkCause> IL-2 by entering the cell cycle and <clueType>avoiding</clueType> apoptosis.</clue>
</event>
<sentence id="S7">Similarly, <term sem="Protein_molecule" id="T28" lex="IL-2">IL-2</term> neither activates <term sem="Protein_family_or_group" id="T29" lex="JNK">JNK</term> nor increases <term sem="Other" id="T30" lex="AP-1_binding_activity"><term sem="Protein_complex" id="T31" lex="AP-1">AP-1</term> binding activity</term> to a consensus <term sem="DNA_domain_or_region" id="T32" lex="o-tetradecanoylphorbol_13-acetate_(TPA)_response_element"><term sem="Organic_compound_other" id="T33" lex="o-tetradecanoylphorbol_13-acetate">o-tetradecanoylphorbol 13-acetate</term> (<term sem="Organic_compound_other" id="T34" lex="TPA">TPA</term>) response element</term>.</sentence>
<event assertion="non-exist" id="E30">
<type class="Positive_regulation" />
<theme idref="T29" />
<cause idref="T28" />
<clue>Similarly, IL-2 neither <clueType>activates</clueType> JNK nor increases AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
</event>
<event id="E31">
<type class="Binding" />
<theme idref="T31" />
<theme idref="T32" />
<clue>Similarly, IL-2 neither activates JNK nor increases AP-1 <clueType>binding</clueType> activity <linkTheme>to</linkTheme> a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
<comment>NER T31 mod</comment>
</event>
<event assertion="non-exist" id="E32">
<type class="Positive_regulation" />
<theme idref="E31" />
<cause idref="T28" />
<clue>Similarly, IL-2 neither activates JNK nor <clueType>increases</clueType> AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
</event>
<sentence id="S8">On the other hand, the <term sem="Protein_family_or_group" id="T35" lex="growth_factor">growth factor</term> does induce the activation of <term sem="Protein_molecule" id="T36" lex="STAT3">STAT3</term> and <term sem="Protein_family_or_group" id="T37" lex="STAT5">STAT5</term> in these cells, as has been previously demonstrated.</sentence>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="T36" />
<clue>On the other hand, the growth factor does induce the <clueType>activation</clueType> <linkTheme>of</linkTheme> STAT3 and STAT5 in these cells, as has been previously demonstrated.</clue>
</event>
<event id="E34">
<type class="Positive_regulation" />
<theme idref="T37" />
<clue>On the other hand, the growth factor does induce the <clueType>activation</clueType> <linkTheme>of</linkTheme> STAT3 and STAT5 in these cells, as has been previously demonstrated.</clue>
</event>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="E33" />
<cause idref="T28" />
<clue>On the other hand, <corefCause>the growth factor</corefCause> does <clueType>induce</clueType> the activation of STAT3 and STAT5 <clueLoc>in these cells</clueLoc>, as has been previously demonstrated.</clue>
</event>
<event id="E36">
<type class="Positive_regulation" />
<theme idref="E34" />
<cause idref="T28" />
<clue>On the other hand, <corefCause>the growth factor</corefCause> does <clueType>induce</clueType> the activation of STAT3 and STAT5 <clueLoc>in these cells</clueLoc>, as has been previously demonstrated.</clue>
</event>
<sentence id="S9">These data show that neither <term sem="Protein_complex" id="T39" lex="NF-kappa_B">NF-kappa B</term> nor <term sem="Other" id="T40" lex="AP-1_activation"><term sem="Protein_complex" id="T41" lex="AP-1">AP-1</term> activation</term> is required for <term sem="Protein_molecule" id="T43" lex="IL-2">IL-2</term>-mediated <term sem="Other" id="A9">survival</term> or <term sem="Other" id="T44" lex="cell_cycle_progression"><term sem="Other" id="A8">cell cycle</term> progression</term> in activated <term sem="Cell_natural" id="T45" lex="primary_human_T_cell">primary human T cells</term>.</sentence>
<event id="E37">
<type class="Positive_regulation" />
<theme idref="A9" />
<cause idref="T43" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-<clueType>mediated</clueType> survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="A8" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-mediated survival or cell cycle <clueType>progression</clueType> in activated primary human T cells.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="E38" />
<cause idref="T43" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-<clueType>mediated</clueType> survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event id="E40">
<type class="Positive_regulation" />
<theme idref="T39" />
<clue>These data show that neither NF-kappa B nor AP-1 <clueType>activation</clueType> is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event id="E41">
<type class="Positive_regulation" />
<theme idref="T41" />
<clue>These data show that neither NF-kappa B nor AP-1 <clueType>activation</clueType> is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event assertion="non-exist" id="E42">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="E40" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E43">
<type class="Positive_regulation" />
<theme idref="E39" />
<cause idref="E40" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E44">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="E41" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E45">
<type class="Positive_regulation" />
<theme idref="E39" />
<cause idref="E41" />
<clue>These data show that neither NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
